CINECA IRIS Institutional Research Information System

AIME, Silvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.283
EU - Europa 18.383
AS - Asia 9.095
AF - Africa 131
SA - Sud America 92
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 22
Totale 54.088
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.913
CN - Cina 4.536
DE - Germania 3.050
IT - Italia 2.904
IE - Irlanda 2.254
SE - Svezia 2.149
SG - Singapore 1.960
UA - Ucraina 1.663
FR - Francia 1.479
FI - Finlandia 1.236
KR - Corea 1.032
DK - Danimarca 1.026
GB - Regno Unito 761
PL - Polonia 529
VN - Vietnam 471
CA - Canada 334
RU - Federazione Russa 308
AT - Austria 286
JP - Giappone 276
IN - India 257
BE - Belgio 182
NL - Olanda 132
ID - Indonesia 131
GR - Grecia 113
HK - Hong Kong 113
ES - Italia 76
SN - Senegal 73
AU - Australia 71
TR - Turchia 64
TW - Taiwan 56
BR - Brasile 44
CH - Svizzera 42
SA - Arabia Saudita 38
CZ - Repubblica Ceca 36
PT - Portogallo 36
IR - Iran 32
MX - Messico 29
IL - Israele 28
RO - Romania 28
NO - Norvegia 24
EU - Europa 21
PH - Filippine 20
AR - Argentina 19
PK - Pakistan 19
MY - Malesia 17
NG - Nigeria 16
HU - Ungheria 13
LT - Lituania 13
ZA - Sudafrica 12
BY - Bielorussia 11
NZ - Nuova Zelanda 11
TH - Thailandia 10
CL - Cile 8
EG - Egitto 8
PE - Perù 8
CO - Colombia 7
CY - Cipro 6
MU - Mauritius 6
JO - Giordania 5
RS - Serbia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
DZ - Algeria 4
HR - Croazia 4
MO - Macao, regione amministrativa speciale della Cina 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AZ - Azerbaigian 3
GT - Guatemala 3
QA - Qatar 3
BO - Bolivia 2
CI - Costa d'Avorio 2
KZ - Kazakistan 2
LI - Liechtenstein 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
PA - Panama 2
SC - Seychelles 2
TG - Togo 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
CM - Camerun 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
MA - Marocco 1
MN - Mongolia 1
MT - Malta 1
PS - Palestinian Territory 1
RE - Reunion 1
TT - Trinidad e Tobago 1
Totale 54.088
Salva come PNG Salva come JPEG
Città #
Chandler 2.965
Beijing 2.854
Ann Arbor 2.583
Santa Clara 2.372
Dublin 2.233
Singapore 1.562
Houston 1.167
Fairfield 1.094
Jacksonville 1.080
Torino 1.011
Villeurbanne 880
Wilmington 829
Dearborn 794
Ashburn 778
Princeton 755
Medford 713
Columbus 621
Nyköping 584
Frankfurt am Main 574
Warsaw 500
Woodbridge 500
Seattle 423
Cambridge 352
Dong Ket 352
Boston 335
Pisa 279
Vienna 278
Redwood City 263
Boardman 256
Guangzhou 251
Milan 233
Turin 229
Fremont 215
Munich 189
Brussels 152
Nanjing 132
Shanghai 121
Norwalk 117
Hangzhou 115
Jakarta 114
Toronto 114
Falls Church 111
Verona 109
Grafing 93
Helsinki 85
New York 83
San Diego 80
West Jordan 74
Hefei 71
Tokyo 71
Düsseldorf 67
London 65
Los Angeles 63
Ottawa 63
Lachine 61
Kunming 58
Pune 55
Hong Kong 51
Mountain View 48
Jinan 44
Philadelphia 44
Wuhan 44
Menlo Park 43
Phoenix 43
Chengdu 42
Padova 42
Montréal 40
Taipei 39
Redmond 37
Piemonte 36
Seoul 36
Nürnberg 32
Zhengzhou 32
Central District 31
Athens 30
Des Moines 30
Nanchang 29
Washington 29
Fuzhou 27
Rome 27
Changsha 25
Duncan 25
Kharkiv 25
Istanbul 24
Hebei 23
Silver Spring 23
Tianjin 23
Harbin 22
Brisbane 20
Chennai 20
Pozzo 20
San Mateo 20
Amsterdam 19
Baltimore 19
Nuremberg 19
Göttingen 18
Hyderabad 17
Shenyang 17
Xiamen 17
Xian 17
Totale 33.447
Salva come PNG Salva come JPEG
Nome #
Boronated Compounds for Imaging Guided BNCT Applications. 509
MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters. 470
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells 419
A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment 391
Assessment of iron absorption in mice by ICP-MS measurements of 57Fe levels 374
In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging 366
The release of Doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model 363
Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting 357
13C MR Hyperpolarization of Lactate by Using ParaHydrogen and Metabolic Transformation in Vitro 337
Preparation and in vitro characterization of chitosan nanobubbles as theranostic agents 332
A Carborane Derivative “Click” Reaction under Heterogeneous Conditions for the Synthesis of a Promising Lipophilic MRI/GdBNCT Agent 324
The hydroboration reaction as a key for a straightforward synthesis of new MRI-NCT agents 308
Proteomic analysis of a genetically modified maize flour carrying Cry1Ab gene and comparison to the corresponding wild-type 295
Hair dye composition 294
Magnetic hyperthermia efficiency and (1)H-NMR relaxation properties of iron oxide/paclitaxel-loaded PLGA nanoparticles 286
Cluster analysis of quantitative parametric maps from DCE-MRI: Application in evaluating heterogeneity of tumor response to antiangiogenic treatment 281
Synthesis of a carborane-containing cholesterol derivative and evaluation as a potential dual agent for MRI/BNCT applications 280
Synthetic Strategies for the Preparation of Lipophilic MRI/GdBNCT Agents 264
1 H-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures 264
An MRI Method To Map Tumor Hypoxia Using Red Blood Cells Loaded with a pO2-Responsive Gd-Agent 260
Gd-AAZTA-MADEC, an improved blood pool agent for DCE-MRI studies on mice on 1 T scanners 256
1,2-Hydroxypyridonate/Terephthalamide Complexes of Gadolinium(III): Synthesis, Stability, Relaxivity, and Water Exchange Properties 254
1,2-Hydroxypyridonates as Contrast Agents for Magnetic Resonance Imaging: TREN-1,2-HOPO 240
A Boron/Gd/LDL adduct for Im aging-guided Neutron Capt ure Therapy 239
Paramagnetic Phospholipid-Based Micelles Targeting VCAM-1 Receptors for MRI Visualization of Inflammation 239
Synthetic strategies for the preparation of lipophilic MRI/GdBNCT agents 237
New Synthetic Strategy of MRI/BNCT Agents Based on Hydroboration Reaction 236
A relaxometric method for the assessment of intestinal permeability based on the oral administration of gadolinium-based MRI contrast agents 234
ParaHydrogen Induced Polarization of 13C carboxylate resonance in acetate and pyruvate 231
Carborane compounds for BNCT-MRI applications: hunting the selectivity towards tumor cells 224
Synthesis and biological evaluation of new dual agentsfor MRI/BNCT applications 223
Synthesis of Gd(III)-C-palmitamidomethyl-C-DOTAMA-C6-o-carborane: a new dual agent for innovative MRI/BNCT applications 221
MR Imaging guided NCT by a dual Gd/B agent targeted to tumor cells via upregulated LDL transporters 219
Towards improved boron neutron capture therapy agents: evaluation of in vitro cellular uptake of a glutamine-functionalized carborane 218
MR Imaging guided NCT by a dual Gd/B agent targeted to tumor cells via upregulated LDL transporters 216
An innovative therapeutic approach for malignant mesothelioma treatment based on the use of Gd/boron multimodal probes for MRI guided BNCT 216
Mesoporous silica nanoparticles functionalized with fluorescent and MRI reporters for the visualization of murine tumors overexpressing αvβ3 receptors 215
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 215
In vivo imaging of tumor metabolism and acidosis by combining PET and MRI-CEST pH imaging 211
Carborane Derivatives as Dual Agents for Boron Neutron Capture Therapy and MRI 210
Design and synthesis of a γ1β8- cyclodextrin oligomer: A new platform with potential application as a dendrimeric multicarrier 204
NEUTRON CAPTURE THERAPY RESEARCH AT INFN AND UNIVERSITY OF PAVIA 200
New Synthetic Strategy of MRI/BNCT Agents Based on Hydroboration Reaction 199
Synthesis and Biological Evaluation of new dual agents for MRI-BNCT applications 198
Sintesi di carborani funzionalizzati per applicazione BNCT 197
The Role of the Amino Protecting Group during Parahydrogenation of Protected Dehydroamino Acids 197
Noninvasive evaluation of renal pH homeostasis after ischemia reperfusion injury by CEST-MRI 190
null 186
EXCI-CEST: Exploiting pharmaceutical excipients as MRI-CEST contrast agents for tumor imaging 186
Assessing the transport rate of hyperpolarized pyruvate and lactate from the intra- to the extracellular space 182
Probing lactate secretion in tumours with hyperpolarised NMR 178
Studies to enhance the hyperpolarization level in PHIP-SAH-produced C13-pyruvate 171
MRI Contrast agents: macrocyclic lanthanide(III) complexes with improved relaxation efficiency 170
Para-hydrogen induced polarization of Si-29 NMR resonances as a potentially useful tool for analytical applications 170
Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging 167
Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging 167
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents 164
Detection of U-87 Tumor Cells by RGD-Functionalized/Gd-Containing Giant Unilamellar Vesicles in Magnetization Transfer Contrast Magnetic Resonance Images 162
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 161
Binding and relaxometric properties of heme complexes with cyanogen bromide fragments of human serum albumin 159
Water Soluble Melanin Derivatives for Dynamic Contrast Enhanced Photoacoustic Imaging of Tumor Vasculature and Response to Antiangiogenic Therapy 159
CEST-MRI studies of cells loaded with lanthanide shift reagents 156
Asparagine in plums detected by CEST–MRI 153
Frequency-Encoded MRI-CEST Agents Based on Paramagnetic Liposomes/RBC Aggregates. 153
Synthesis and characterization of a Gd(III) based contrast agent responsive to thiol containing compounds 151
Synthesis and characterization of an MRI Gd-based probe designed to target the translocator protein 150
Modulation of the antioxidant activity of HO center dot scavengers by albumin binding: a F-19-NMR study 148
Release of a paramagnetic magnetic resonance imaging agent from liposomes triggered by low Intensity non-focused ultrasound 147
Lipid-Based Nanoparticles in Cardiovascular Molecular Imaging 146
Optimizing the high-field relaxivity by self-assembling of macrocyclic Gd(iii) complexes 144
Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. 143
EFFECT OF IBUPROFEN AND WARFARIN ON THE ALLOSTERIC PROPERTIES OF HAEM-HUMAN SERUM ALBUMIN 143
Water exchange across the erythrocyte plasma membrane studied by HR-MAS NMR spectroscopy 142
Ferritin Decorated PLGA/Paclitaxel Loaded Nanoparticles Endowed with an Enhanced Toxicity Toward MCF-7 Breast Tumor Cells 141
Characterization of human hair melanin and its degradation products by means of magnetic resonance techniques 140
Iron oxide/PLGA nanoparticles for magnetically controlled drug release 140
Insights on the relaxation of liposomes encapsulating paramagnetic Ln-based complexes 138
Carbon-metal hydrogen interchange in organometal clusters of ruthenium and osmium 137
Endogenous glutamine decrease is associated with pancreatic cancer progression 137
In Vivo Magnetic Resonance Imaging Detection of Paramagnetic Liposomes Loaded with Amphiphilic Gadolinium(III) Complexes: Impact of Molecular Structure on Relaxivity and Excretion Efficiency 135
MEMRI and tumors: a method for the evaluation of the contribution of Mn(II) ions in the extracellular compartment 134
Lanthanide(III) Chelates for NMR Biomedical Applications 131
Determination of ferric heme-human serum albumin by 1H NMR relaxometry 131
Thermodynamic analysis of hydration in human serum heme-albumin 131
Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin. 128
Proteomics as a tool to improve investigation of substantial equivalence in genetically modified organisms: The case of a virus-resistant tomato 125
Relaxometric studies for food characterization: the case of balsamic and traditional balsamic vinegars 125
Efficient Route to Label Mesenchymal Stromal Cell-Derived Extracellular Vesicles 125
Fast field-cycling magnetic resonance imaging 124
A mechanistic study of the reaction of H2Os3(CO)10 with terminal alkynes 123
Relaxometric Investigations and MRI Evaluation of a Liposome-Loaded pH-Responsive Gadolinium(III) Complex 122
13C Solid State CPMAS NMR Studies of EDTA Complexes 121
RELAXOMETRIC CHARACTERIZATION OF HUMAN HEMALBUMIN 121
Re-evaluation of the water exchange lifetime value across red blood cell membrane 121
Preclinical studies of MRI guided BNCT at Torino and Pavia Universities 121
A global view of standards for open image data formats and repositories 120
Modulation of the Prototropic Exchange Rate in pH-Responsive Yb-HPDO3A Derivatives as ParaCEST Agents 118
Successful entrapping of liposomes in glucan particles: An innovative micron-sized carrier to deliver water-soluble molecules 117
New cyclodextrin dimers and trimers capable of forming supramolecular adducts with shape-specific ligands 117
Facile oxidative addition/reductive elimination of HX (X = Cl, Br, I) on (mu-H)(2)Os-3(CO)(10) 116
Totale 20.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.146
article - articoli 0
book - libri 0
conference - conferenze 9.428
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.133 0 0 0 0 0 1.156 877 444 901 647 673 435
2020/20215.977 571 320 444 302 444 318 543 189 804 685 439 918
2021/20228.002 423 347 398 619 566 508 564 556 319 612 1.549 1.541
2022/20239.488 1.083 605 249 979 979 2.652 879 561 868 109 362 162
2023/20243.586 520 712 193 166 216 356 106 196 40 217 291 573
2024/20256.419 111 738 357 1.196 3.038 979 0 0 0 0 0 0
Totale 55.932